AMELIOR
Cumberland Pharmaceuticals Inc.
| Research |
OneLook
Acronym Finder
|
| Serial Number | 75897617 |
| Registration Number | 2854095 |
| Mark Drawing Code | 1000: Typeset: Word(s)/letter(s)/number(s) |
| Cancellation Code | 2 |
| Attorney Name | Reber M. Boult |
| Law Office Assigned | M60 |
| Employee Name | FRENCH, CURTIS W |
Timeline
| 2000-01-18 | Application Filed |
| 2001-05-29 | Published for Opposition |
| 2004-01-19 | Date of First Use |
| 2004-06-15 | Trademark Registered |
| 2004-07-07 | Location: FILE REPOSITORY (FRANCONIA) |
| 2011-01-21 | Cancelled |
| 2011-01-21 | Status: Dead/Cancelled |
| 2018-07-08 | Transaction Date |
Trademark Applicants & Owners
| Owner: |  Cumberland Pharmaceuticals Inc. |
| Address | 2525 WEST END AVENUE Nashville TN 37203 |
| Legal Entity Type | Corporation |
| Legal Entity State | TN |
Documents
Click the blue "Refresh" button to load certificates, specimines, application, and other documents.
Attorney of Record
Good, Services, and Codes
| International Codes: | 5 |
| U.S. Codes: | 006,018,044,046,051,052 |
| Type Code | Type |
|---|---|
| GS0051 | PHARMACEUTICAL PREPARATIONS FOR USE IN THE TREATMENT OF FEVER, PAIN, CLOSURE OF PATENT DUCTUS ARTERIOSIS, LACTIC ACIDOTIS, SEPSIS, SEVERE SEPSIS, AND SEPTICEMIA, AND CYCLOOXYGENASE I AND II INHIBITION |
Trademark Filing History
| Description | Date | Event Coding |
|---|---|---|
| ASSIGNED TO EXAMINER | 2000-08-15 | 1 DOCK D:Assigned to Examiner |
| NON-FINAL ACTION MAILED | 2000-08-30 | 2 CNRT F:First Action |
| CORRESPONDENCE RECEIVED IN LAW OFFICE | 2000-09-08 | 3 CRFA I:Incoming Correspondence |
| APPROVED FOR PUB - PRINCIPAL REGISTER | 2001-01-31 | 4 CNSA P: |
| NOTICE OF PUBLICATION | 2001-05-16 | 5 NPUB O:Outgoing Correspondence |
| PUBLISHED FOR OPPOSITION | 2001-05-29 | 6 PUBO A:Allowance for Publication |
| NOA MAILED - SOU REQUIRED FROM APPLICANT | 2001-08-21 | 7 NOAM O:Outgoing Correspondence |
| EXTENSION 1 FILED | 2001-10-30 | 8 EXT1 S: |
| EXTENSION 1 GRANTED | 2001-11-09 | 9 EX1G S: |
| PAPER RECEIVED | 2002-05-07 | 10 MAIL I:Incoming Correspondence |
| PAPER RECEIVED | 2002-08-16 | 11 MAIL I:Incoming Correspondence |
| EXTENSION 2 FILED | 2002-08-15 | 12 EXT2 S: |
| EXTENSION 2 GRANTED | 2002-09-17 | 13 EX2G S: |
| TEAS EXTENSION RECEIVED | 2003-02-19 | 14 EEXT I:Incoming Correspondence |
| EXTENSION 3 FILED | 2003-02-19 | 15 EXT3 S: |
| EXTENSION 3 GRANTED | 2003-04-15 | 16 EX3G S: |
| PAPER RECEIVED | 2003-05-27 | 17 MAIL I:Incoming Correspondence |
| TEAS EXTENSION RECEIVED | 2003-08-21 | 18 EEXT I:Incoming Correspondence |
| EXTENSION 4 FILED | 2003-08-21 | 19 EXT4 S: |
| EXTENSION 4 GRANTED | 2003-08-28 | 20 EX4G S: |
| TEAS STATEMENT OF USE RECEIVED | 2004-02-12 | 21 EISU I:Incoming Correspondence |
| USE AMENDMENT FILED | 2004-02-12 | 22 IUAF S: |
| STATEMENT OF USE PROCESSING COMPLETE | 2004-03-17 | 23 SUPC I:Incoming Correspondence |
| CASE FILE IN TICRS | 2004-03-23 | 24 CFIT O:Outgoing Correspondence |
| CASE FILE IN TICRS | 2004-03-23 | 25 CFIT O:Outgoing Correspondence |
| ASSIGNED TO EXAMINER | 2004-03-24 | 26 DOCK D:Assigned to Examiner |
| ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | 2004-04-02 | 27 CNPR P: |
| REGISTERED-PRINCIPAL REGISTER | 2004-06-15 | 28 R.PR A:Allowance for Publication |
| ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY | 2009-07-29 | 29 ASCK I:Incoming Correspondence |
| CANCELLED SEC. 8 (6-YR) | 2011-01-21 | 30 C8.. O:Outgoing Correspondence |
| ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY | 2014-08-20 | 31 ASCK I:Incoming Correspondence |
Similar Marks
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
 AMELIOR 98080827 not registered Live/Pending |
NUTRISORB INTERNATIONAL 2023-07-12 |
 AMELIOR 87854576 5636831 Live/Registered |
Brodies LLP 2018-03-28 |
 AMELIOR 75897617 2854095 Dead/Cancelled |
Cumberland Pharmaceuticals Inc. 2000-01-18 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 